Pharmaceuticals remain a draw for ESG investors
EdenTree’s Patel says industry’s response to Covid and innovation keep it attractive to ESG investors
Natasha Turner
-
-
Investors snap up sustainable funds as UK heatwaves continue
‘This year has made a lot more people think about climate change’
-
Green bond issuance climbs as companies look to finance net-zero transition
More than 835 bonds have raised $245bn since the start of the year
-
Four actions investors can take against human rights abuses
Federated Hermes’ Leon Kamhi says the business case for corporate action is compelling
-
ESG: A cautionary tale for the Lionesses?
Julia Dreblow says the tide has turned for women’s football, like it did for ESG
-
StanChart hires climate change leader from Google
Kerry Constabile joins the bank to oversee net-zero target setting
-
Abe’s transformation of Japanese corporate governance will live on
Sparx’s Yu Shimizu outlines three positive governance developments here to stay
-
Investment world must improve sustainability reporting
Globally, only 3% of companies report more than 70% of the 14 mandatory PAIs
-
Sustainable Summer with Natasha Turner: Communities and cutting consumption
ESG Clarity global deputy editor on mental health, moving and mountains
-
Companies must look after their workforces
Latest episode of ESG Out Loud considers social factors and learns about the Smurfs project
-
SFDR could revolutionise reporting but don’t wait for data
Globally, only 3% of companies report more than 70% of the 14 mandatory PAIs
-
Ayres Punchard Q&A: Conflating terminology is doing a massive disservice
Managing director Chris Welsford says industry could be headed into ‘really bad places’